In the Media

  • Hot Seat Extra: The Fentanyl Crisis

    Don Kyle, chief executive officer of the National Center for Wellness and Recovery, was a recent guest on ‘Hot Seat.’ Tune in as he discusses the fentanyl crisis, important research and hope for individuals and families facing pain and addiction. Remember, there is no shame in seeking help. Contact the OSU NCWR Addiction and Recovery…

  • Dr. Kelly Dunn, executive director of clinical treatment at the National Center for Wellness and Recovery speaks with Denver7, about the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” Dunn said in part, “With addiction care; it’s most successful when there’s as little obstacle as possible to access that care.”

  • “This drug overdose epidemic in the United States, it really has touched all communities, all states and almost now, everyone knows somebody who’s been touched. This doesn’t just apply to students. This is a message everyone needs to be aware of,” Kyle said.

  • In March 2019, when then-Oklahoma Attorney General Mike Hunter announced a $270 million settlement with opioid manufacturer Purdue Pharma and its founding Sackler family, he predicted it would transform a year-old unit within Oklahoma State University’s Tulsa-based Center for Health Sciences into one of the foremost addiction research and treatment centers in the country.

  • “We’ve all been working in pain and addiction research for decades,” said Don Kyle, the CEO of OSU’s National Center for Wellness and Recovery. ” It really just occurred to us, we could do things together that we would never be able to do by ourselves.”

  • The National Center for Wellness and Recovery has launched the ‘One Pill Can Kill’ campaign to educate young adults and parents in Oklahoma about the rise in deaths related to fentanyl poisoning. Don Kyle, chief executive officer of NCWR, highlights the danger of counterfeit pills, often indistinguishable from legitimate prescriptions, flooding the market through social…